Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke
Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."
Drinking coffee may reduce risk of recurrent AFib
Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.
AI-enabled coronary plaque quantification outperforms traditional risk scores
Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.
FDA clears AI-powered ‘thermometer of the future’ with ECG sensors
BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

Duke University is heading a project that for the first time in the United States, drones will be used to quickly deliver automated external defibrillators (AEDs) to bystanders who call 911 for patients in cardiac arrest. The idea is to deliver an AED faster than police or paramedics could arrive on scene, saving critical minutes in an effort to boost survival.

Drones deliver AEDs for the first time in the United States

“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

Drinking coffee may reduce risk of recurrent AFib

Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.

AI-enabled coronary plaque quantification outperforms traditional risk scores

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.

FDA clears AI-powered ‘thermometer of the future’ with ECG sensors

BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.

medicare advantage rural healthcare hospitals

Cardiologists work to eliminate ‘cardiology deserts’ found in many rural communities

The Association of Black Cardiologists hopes to improve widespread disparities in care through the use of patient education, free diagnostic heart screenings and other proven methods.

‘Unprecedented’: Single dose of new gene-editing therapy lowers cholesterol, triglycerides

First-in-human data suggest the therapy, CTX310, could be a breakthrough for patients with lipid disorders.

New pill lowers cholesterol for patients already on statins—no needles required

The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine.